Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-04

Clinical Trial Update: The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

View source ↗

Summary

A completed clinical trial evaluating the effects of Sifrol on tremor and depression in patients with Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sifrol (ropinirole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Status: COMPLETED